Compare with Takeda Pharmaceutical Company Limited
−0.28 USD
−1.01 B USD
29.90 B USD
3.16 B
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Profile
Sector
Industry
CEO
Julie So-Young Kim
Website
Headquarters
Osaka
Founded
1781
IPO date
May 16, 1949
ISIN
US8740602052
CUSIP
874060205
FIGI
BBG000LF8708
Identifiers
ISIN US8740602052
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following business divisions: Gastrointestinal Diseases, Rare Diseases, Plasma-Derived Therapies, Oncology, Vaccines, and Neuroscience The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
TAK : SQUARE ROOT / POSITION TRADEThe Square Root set-up appears in large cap stocks that underwent capitulation. Because large caps are heavily traded, the high liquidity reduces sharp movements. This set-up is best for position trading and usually is a sweet spot for establishing a core position on a stock that potentially has lo
Big Bull Run, 30+ short term, 50+ long term
30 within month
50+ within year
Takeda has made significant moves in the development of it's global pipeline. From the MASSIVE moves with various COVID vaccine manufacturers, to acquiring smaller Immunology biotech startups, and increase in Boston research sphere. I am the most bullish on Takeda
4502 (TSE) - Be CarefullGreetings
Humbled, we would like to thanks for your support who has already liked, commented and followed us. Your support, strengthens us, to help in analyzing the market. If you have any questions, do not be hesitant to send us message (inbox). Our Service : Signal recomendation, Trading Course, P
TAK - Takeda Pharma - TO THE MOON? - Major Covid 19 Discovery Researchers tout 'major scientifc discovery' in $14M study for COVID-19 treatment
www.cbc.ca
Close to 4,500 people participated in the study, lead researcher calls findings 'substantial' and 'robust'
CBC News · Posted: Jan 23, 2021 4:07 PM ET | Last Updated: January 23
The $14-million study was fu
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
6.011% YTM
Maturity dateJul 5, 2064
Coupon5.80% (Fixed)
5.957% YTM
Maturity dateJul 7, 2055
Coupon5.90% (Fixed)
5.919% YTM
Maturity dateJul 5, 2054
Coupon5.65% (Fixed)
5.914% YTM
Maturity dateJul 9, 2060
Coupon3.38% (Fixed)
5.910% YTM
Maturity dateJun 23, 2045
Coupon5.25% (Fixed)
5.897% YTM
Maturity dateJul 9, 2050
Coupon3.18% (Fixed)
5.811% YTM
Maturity dateJul 5, 2044
Coupon5.65% (Fixed)
5.655% YTM
Maturity dateJul 9, 2040
Coupon3.03% (Fixed)
5.329% YTM
Maturity dateJul 7, 2035
Coupon5.20% (Fixed)
5.166% YTM
Maturity dateJul 5, 2034
Coupon5.30% (Fixed)
4.938% YTM
Maturity dateSep 23, 2026
Coupon3.20% (Fixed)
See all TAK bonds
Weight0.41%
Market value33.43 M
Weight2.97%
Market value28.45 M
Weight0.05%
Market value8.97 M
Weight0.26%
Market value2.91 M
Weight0.05%
Market value1.49 M
Weight0.33%
Market value989.19 K
Weight2.23%
Market value936.26 K
Weight0.68%
Market value670.46 K
Weight0.06%
Market value261.61 K
Weight1.88%
Market value168.60 K
Weight0.66%
Market value156.78 K
Explore more ETFs









